Gemfibrozil-d6 – 500 µg

Brand:
Cayman
CAS:
1184986-45-5
Storage:
-20
UN-No:
- /

Gemfibrozil-d6 is intended for use as an internal standard for the quantification of gemfibrozil (Item No. 14835) by GC- or LC-MS. Gemfibrozil is a peroxisome proliferator-activated reporter α (PPARα) and PPARγ agonist (EC50s = 193.3 and 147.8 µM, respectively, in transactivation assays).{23621} In vivo, gemfibrozil (50 mg/kg, p.o.) reduces serum total cholesterol, triglyceride, and LDL levels in a rat model of high-cholesterol diet-induced hyperlipidemia.{54664} Gemfibrozil (100 mg/kg per day) reduces atherosclerotic plaque area, superoxide production, and expression of the genes encoding the NF-κB subunit p65 and chemokine (C-C) motif ligand 2 (CCL2) in ApoE-/- mice.{54665} Formulations containing gemfibrozil have been used in the treatment of high cholesterol.  

 

Available on backorder

SKU: 31915 - 500 µg Category:

Description

An internal standard for the quantification of gemfibrozil by GC- or LC-MS


Formal name: 5-(2,5-dimethylphenoxy)-2,2-di(methyl-d3)-pentanoic acid

Synonyms:  CI-719-d6

Molecular weight: 256.4

CAS: 1184986-45-5

Purity: ≥99% deuterated forms (d1-d6)

Formulation: A solid